Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus

Ann Rheum Dis. 2019 Aug;78(8):1140-1142. doi: 10.1136/annrheumdis-2019-215200. Epub 2019 Mar 28.
No abstract available

Keywords: autoantibodies; b cells; dmards (biologic); systemic lupus erythematosus; treatment.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Autoantibodies / drug effects*
  • Autoantibodies / immunology
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Hospitals, University
  • Humans
  • Infusions, Intravenous / adverse effects
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use
  • Treatment Outcome
  • United Kingdom

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Rituximab